CA
CPBIO Holding Company Limited
CAIHF · OTC
$1.07 +0.00% (+$0.00)
Market Cap $829.2M
P/E Ratio 33.94x
Div. Yield -
ROE 8.74%
Bulios Fair Price
$0.77
27.9% downside
Current Price
$1.07
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CAIHF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
38 /100
Fair P/B 2.82x
P/S 1.96x
P/E 33.94x
Growth
91 /100
Growing Book val. growth 6.31%
Rev. growth 49.81%
FCF growth N/A
Profitability
23 /100
Weak FCF margin 0.00%
Op. margin 7.07%
Gross margin 16.60%
Quality
42 /100
Average Asset turnover 0.84x
ROA 4.84%
ROIC 5.92%
Debt
91 /100
Low Net debt/EBITDA 1.23x
Int. coverage 25.44x
Debt/Equity 0.26x
Stability
11 /100
Unstable Profitable years 3
EPS volatility 103.49%
Beta 3.98x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CAIHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chawalit Na Muangtoun
Employees
900
Headquarters
Hong Kong